反应详情

By the reaction and treatment in the same manner as in Example 271 using 5-benzyloxy-N-(6-methoxypyridin-3-yl)-N-[(pyrazol-4-yl)methyl]-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.94 g) and 6-chloromethyl-2-(dimethylamino)pyridine (0.68 g) as starting materials, 5-benzyloxy-N-({1-[(6-(dimethylamino)pyridin-2-yl)methyl]pyrazol-4-yl}methyl)-N-(6-methoxypyridin-3-yl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.31 g) was obtained. 1H-NMR (CDCl3) δ: 1.38-1.67 (1H, m), 1.73-2.07 (3H, m), 2.61-2.82 (2H, m), 3.04 (6H, s), 3.59-3.72 (1H, m), 3.93 (3H, s), 4.64 (1H, d, J=14.4 Hz), 4.83 (1H, d, J=14.4 Hz), 5.03 (2H, s), 5.21 (2H, s), 6.18 (1H, d, J=7.2 Hz), 6.40 (1H, d, J=8.4 Hz), 6.54 (1H, d, J=7.5 Hz), 6.62-6.76 (2H, m), 7.01 (1H, t, J=8.0 Hz), 7.21-7.52 (9H, m), 7.99 (1H, d, J=2.4 Hz).